A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.

TY - JOUR

T1 - A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.

AU - Berdeja, Jesus G

AU - Gregory, Tara K

AU - Faber, Edward A

AU - Hart, Lowell L

AU - Mace, Joseph R

AU - Arrowsmith, Edward R

AU - Flinn, Ian W

AU - Matous, Jeffrey V

N1 - Jesus G. Berdeja, 1 , 2 Tara K. Gregory, 1 , 3 Edward A. Faber, 1 , 4 Lowell L. Hart, 1 , 5 Joseph R. Mace, 1 , 6 Edward R. Arrowsmith, 1 , 7 Ian W. Flinn, 1 , 2 and Jeffrey V.

PY - 2021/1/9

Y1 - 2021/1/9

UR - https://europepmc.org/article/MED/33421178

U2 - 10.1002/AJH.26088

DO - 10.1002/AJH.26088

M3 - Article

SN - 1096-8652

VL - 96

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -